AN ACT REQUIRING HEALTH INSURANCE COVERAGE FOR BIOMARKER TESTING.

SB 391 requires all individual and group health insurance plans to cover biomarker testing, which detects biological markers in blood or tissue for medical diagnosis or treatment. This law directly affects patients who need these tests, ensuring insurers cannot deny coverage for them. The key provision amends insurance regulations to mandate this coverage under Chapter 700c, applying to standard private health insurance policies. It creates a concrete policy change by eliminating coverage gaps for this specific medical testing.